These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25684635)

  • 1. Effects of receptor tyrosine kinase inhibitors on VEGF165 a- and VEGF165 b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2.
    Carter JJ; Wheal AJ; Hill SJ; Woolard J
    Br J Pharmacol; 2015 Jun; 172(12):3141-50. PubMed ID: 25684635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time analysis of the binding of fluorescent VEGF
    Kilpatrick LE; Friedman-Ohana R; Alcobia DC; Riching K; Peach CJ; Wheal AJ; Briddon SJ; Robers MB; Zimmerman K; Machleidt T; Wood KV; Woolard J; Hill SJ
    Biochem Pharmacol; 2017 Jul; 136():62-75. PubMed ID: 28392095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the ligand-binding properties of fluorescent VEGF-A isoforms to VEGF receptor 2 in living cells and membrane preparations using NanoBRET.
    Peach CJ; Kilpatrick LE; Woolard J; Hill SJ
    Br J Pharmacol; 2019 Sep; 176(17):3220-3235. PubMed ID: 31162634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis.
    Kankanala J; Latham AM; Johnson AP; Homer-Vanniasinkam S; Fishwick CW; Ponnambalam S
    Br J Pharmacol; 2012 May; 166(2):737-48. PubMed ID: 22141913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer.
    Zhao X; Wang Q; Yang S; Chen C; Li X; Liu J; Zou Z; Cai D
    Eur J Pharmacol; 2016 Jun; 781():60-8. PubMed ID: 27041643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolinones and anilinophthalazines differentially target VEGF-A- and basic fibroblast growth factor-mediated responses in primary human endothelial cells.
    Latham AM; Bruns AF; Kankanala J; Johnson AP; Fishwick CW; Homer-Vanniasinkam S; Ponnambalam S
    Br J Pharmacol; 2012 Jan; 165(1):245-59. PubMed ID: 21699503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of NanoBiT and NanoBRET to monitor fluorescent VEGF-A binding kinetics to VEGFR2/NRP1 heteromeric complexes in living cells.
    Peach CJ; Kilpatrick LE; Woolard J; Hill SJ
    Br J Pharmacol; 2021 Jun; 178(12):2393-2411. PubMed ID: 33655497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer.
    Devery AM; Wadekar R; Bokobza SM; Weber AM; Jiang Y; Ryan AJ
    Int J Oncol; 2015 Sep; 47(3):849-56. PubMed ID: 26179332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of tyrosine kinase inhibitor-receptor interactions at VEGFR2 using sunitinib-red and nanoBRET.
    Van Daele M; Kilpatrick LE; Woolard J; Hill SJ
    Biochem Pharmacol; 2023 Aug; 214():115672. PubMed ID: 37406966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.
    Peach CJ; Mignone VW; Arruda MA; Alcobia DC; Hill SJ; Kilpatrick LE; Woolard J
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma.
    Jinnin M; Medici D; Park L; Limaye N; Liu Y; Boscolo E; Bischoff J; Vikkula M; Boye E; Olsen BR
    Nat Med; 2008 Nov; 14(11):1236-46. PubMed ID: 18931684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells.
    Gomes E; Papa L; Hao T; Rockwell P
    Mol Cell Biochem; 2007 Nov; 305(1-2):179-90. PubMed ID: 17646929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors.
    Amino N; Ideyama Y; Yamano M; Kuromitsu S; Tajinda K; Samizu K; Hisamichi H; Matsuhisa A; Shirasuna K; Kudoh M; Shibasaki M
    Clin Cancer Res; 2006 Mar; 12(5):1630-8. PubMed ID: 16533791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide approaches reveal functional vascular endothelial growth factor (VEGF)-inducible nuclear factor of activated T cells (NFAT) c1 binding to angiogenesis-related genes in the endothelium.
    Suehiro J; Kanki Y; Makihara C; Schadler K; Miura M; Manabe Y; Aburatani H; Kodama T; Minami T
    J Biol Chem; 2014 Oct; 289(42):29044-59. PubMed ID: 25157100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H2O2.
    González-Pacheco FR; Deudero JJ; Castellanos MC; Castilla MA; Alvarez-Arroyo MV; Yagüe S; Caramelo C
    Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1395-401. PubMed ID: 16899768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo.
    Saraswati S; Agrawal SS
    Cancer Lett; 2013 May; 332(1):83-93. PubMed ID: 23348691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoluciferase Reporter Gene System Directed by Tandemly Repeated Pseudo-Palindromic NFAT-Response Elements Facilitates Analysis of Biological Endpoint Effects of Cellular Ca
    Zhang W; Takahara T; Achiha T; Shibata H; Maki M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis.
    Bruns AF; Bao L; Walker JH; Ponnambalam S
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1193-7. PubMed ID: 19909245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.